State of the Heart 2020

Details & Video

State of the Heart 2020 Session 1 banner

Program details and agenda: Select TABS on the left (computer) or SCROLL DOWN (phone)

Program Time: 90 minute sessions - This program is a recording of a live broadcast.
Accreditation-CME Credits: This program is not accredited. Physicians may earn self-learning credits through active steps. Instructions will be provided in the completion certificate.
Target Audience: General Practitioners, Specialists, Nurses, Nurse Practitioners, Pharmacists, and Other Allied Health Professionals

The program was developed by the Canadian Collaborative Research Network and was presented as three live virtual events in July/August 2020.  We are pleased to make the recordings of these live sessions available to you through MD-Online.  Please select the sessions below to participate.  The PROGRAM AGENDA is available here. The PROGRAM SLIDES are available from the CCRN booth in the virtual exhibit hall link below.

Thank you to our OnDemand sponsors who made it possible for us to share the recordings of this program.

CLICK TO VISIT THE VIRTUAL EXHIBIT HALL

The following sponsors provided support to CCRN for the OnDemand recording through an unrestricted educational grant:

Overview & Objectives

State of the Heart 2020 Session 1

Target Audience: General Practitioners, Specialists, Nurses, Nurse Practitioners, Pharmacists, and Other Allied Health Professionals.

CCRN sm

The State of the Heart program was developed by the Canadian Collaborative Research Network and has been specifically designed for general practitioners, specialists, nurse practitioners, nurses, pharmacists, technicians and other allied health professionals who have an interest in cardiovascular disease. This program covers the latest topics in cardiovascular and metabolic disease, guidelines, late-breaking clinical trial results, and addresses patient care issues encountered in daily practice. For this program, CCRN hosts an outstanding faculty of Canadian and international leaders that provide excellent teaching and offer opportunity for group discussion surrounding real-world implications of the current evidence.




Planning Committee

Planning Committee

Milan Gupta
Milan Gupta
MD, FRCPC, FCCS
Brampton, ON


Rob Hegele
Rob Hegele
MD, FRCPC, FACP, FAHA, FCAHS, FCCS
London, Ontario


Alan Bell
Alan Bell
MD, CCFP
Toronto, ON


Ajay Kapur
Ajay Kapur
MD, FRCPC
Toronto, ON


Agenda

Agenda

Program ChapterDuration
(Min:Sec)
&
Presenter
Session 1 - Beyond statins: PCKS9 inhibitors following acute coronary syndromes – ODYSSEY Outcomes and EVOPACS
Rob Hegele
Session 1 - Beyond statins: Icosapent ethyl and the REDUCE-IT study
Milan Gupta
Session 1 - Does the PARAGON HF study provide a new option for treatment in HFpEF?
Shelley Zieroth
Session 1 - Is there an interaction between ACEi/ARB and COVID-19?
Nadia Khan
Session 2 - Antithrombotic combinations for AF with concomitant ACS/ PCI– clearing the confusion
Alan Bell
Session 2 - Cardiorenal protection in diabetes: Should SGLT2 inhibitors and GLP1 agonists be first-line therapy?
Hertzel Gerstein
Session 2 - Is dapagliflozin the new darling in heart failure management?
Nadia Giannetti
Session 2 - LDL control with twice-yearly injections – will ORION deliver?
Rob Hegele
Session 3 - Is colchicine a cardiovascular drug? Insights from the COLCOT study
Jean-Claude Tardif
Session 3 - Is revascularization warranted for stable ASCVD? The ISCHEMIA study
G.B. John Mancini
Session 3 - Peripheral arterial disease – underdiagnosed and undertreated
Milan Gupta
Session 3 - Cardiovascular safety of cannabis
Paul Oh


Sponsorship

CCRN sm

This program was developed by the Canadian Collaborative Research Network and made possible through an educational grant from BMS/Pfizer Alliance, HLS Therapeutics, Boehringer Ingelheim, Novartis, Sanofi, Amgen

The OnDemand presentations were made possible with additional support from: